Regeneron Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
REGN
CUSIP
75886F107
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 1,303 91.0 M $51.2 B
2025 Q2 1,281 90.5 M $47.5 B
2025 Q1 1,356 92.2 M $58.4 B
2024 Q4 1,406 93.5 M $66.6 B
2024 Q3 1,473 102 M $106 B
2024 Q2 1,413 104 M $109 B
2024 Q1 1,400 104 M $99.3 B
2023 Q4 1,354 100 M $88.0 B
2023 Q3 1,254 91.3 M $75.1 B
2023 Q2 1,236 92.6 M $66.1 B
2023 Q1 1,261 99.1 M $76.1 B
2022 Q4 1,224 99.2 M $70.8 B
2022 Q3 1,151 93.4 M $64.3 B
2022 Q2 1,124 93.4 M $55.2 B
2022 Q1 1,160 92.9 M $64.8 B
2021 Q4 1,145 90.8 M $57.3 B
2021 Q3 1,081 90.3 M $54.4 B
2021 Q2 1,031 89.1 M $49.7 B
2021 Q1 977 89.7 M $42.4 B
2020 Q4 973 91.5 M $44.8 B
2020 Q3 969 92.4 M $51.8 B
2020 Q2 993 93.1 M $58.0 B
2020 Q1 886 76.1 M $37.1 B
2019 Q4 764 75.3 M $28.3 B
2019 Q3 693 74.5 M $20.6 B
2019 Q2 739 74.6 M $23.3 B
2019 Q1 783 74.1 M $30.4 B
2018 Q4 735 74.4 M $27.8 B
2018 Q3 721 75.2 M $30.4 B
2018 Q2 690 73.3 M $25.3 B
2018 Q1 689 73.6 M $25.3 B
2017 Q4 710 71.6 M $26.9 B
2017 Q3 674 72.4 M $32.4 B
2017 Q2 667 73.1 M $35.9 B
2017 Q1 643 72.3 M $28.0 B
2016 Q4 648 72.2 M $26.5 B
2016 Q3 615 73.6 M $29.6 B
2016 Q2 604 72.6 M $25.4 B
2016 Q1 595 79.7 M $26.2 B
2015 Q4 633 73.9 M $42.5 B
2015 Q3 608 75.4 M $37.1 B
2015 Q2 586 73.9 M $37.7 B
2015 Q1 544 73.1 M $33.0 B
2014 Q4 559 72.8 M $30.0 B
2014 Q3 508 71.7 M $27.9 B
2014 Q2 481 75.2 M $21.6 B
2014 Q1 488 73.5 M $22.3 B